VISTEON CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data VISTEON CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,161	3,146	2,984	2,945	2,548	2,773	3,756	3,954	3,866	3,768
Cost of revenue	2,705	2,655	2,573	2,621	2,303	2,519	3,388	3,467	3,335	3,236
Gross profit	456	491	411	324	245	254	368	487	531	532
Research and development	295	253	286	300	201	191	196	210	191	220
Selling, general and administrative	224	226	193	221	193	175	188	207	207	202
Interest expense	18	21	14	13	16	10	14	17	15	13
Interest income	6	5	7	4	5	2	4	10	17	22
Other non-operating income		-8	8	-4	-9	-5
Pre-tax income	161	223	216	106	-20	81	175	257	298	338
Income tax	30	48	43	24	28	31	45	-330	-8	125
Income from continuing operations	115	159	163	71	-56	41
Net income to minority interests	16	16	10	11	8	9	6	19	10	12
Net income	75	176	164	70	-56	41	124	568	296	201
EPS, basic	2.50	6.51	6.50	2.91	-2.35	1.71	5.15	20.21	10.72	7.39
EPS, diluted	2.48	6.39	6.45	2.90	-2.35	1.68	5.08	19.93	10.61	7.28
Shares, basic (weighted)	29.9	27	25.2	24	23.9	24	24	28.1	27.6	27.2
Shares, diluted (weighted)	30.3	27.5	25.4	24.1	23.9	24.3	24.4	28.5	27.9	27.6
Dividend per share	50.73									0.38

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	878	706	463	466	496	452	520	515	623	771
Short-term investments	0
Receivables	505	530	486	514	484	549	672	666	578	613
Inventory	151	189	184	169	177	262	348	298	283	269
Other current assets	170	175	159	193	180	158	167	134	109	130
Total current assets	1,708	1,603	1,296	1,345	1,341	1,424	1,710	1,616	1,596	1,785
Property, plant and equipment	345	377	397	436	436	388	364	418	452	524
Lease right-of-use assets			0	165	172	139	124	109	100	126
Goodwill	45	47	0	0
Intangible assets	84	85	82	81	78	68	54	46	71	109
Other non-current assets	146	151	143	150	135	111	62	75	94	189
Total assets	2,373	2,304	2,007	2,271	2,271	2,234	2,450	2,727	2,966	3,386
Accounts payable	463	470	436	511	500	522	657	551	505	540
Accrued liabilities	103	105	67	73	83	80	90	99	107	122
Deferred revenue	14	18	16	22	46	69	55	57	48	55
Short-term debt	36	46	57	37	0	4	13	18	18	18
Total current liabilities	911	801	721	798	824	852	1,035	931	916	992
Long-term debt	346	347	348	348	349	349	336	318	301	283
Lease liabilities			0	139	146	117	99	79	78	109
Other non-current liabilities	69	95	76	72	92	75	64	85	87	212
Total liabilities	1,649	1,543	1,425	1,676	1,761	1,618	1,676	1,522	1,552	1,735
Total debt	346	347	348	348	349	349	336	318	301	283
Paid-in capital	1,327	1,339	1,335	1,342	1,348	1,349	1,352	1,356	1,376	1,398
Retained earnings	1,269	1,445	1,609	1,679	1,623	1,664	1,788	2,274	2,652	2,838
Treasury stock	-1,778	-1,974	-2,264	-2,275	-2,281	-2,269	-2,253	-2,339	-2,390	-2,429
Other comprehensive income	-233	-174	-216	-267	-304	-229	-213	-254	-306	-240
Shareholders' equity	586	637	465	480	387	516	675	1,038	1,333	1,568
Minority interests	138	124	117	115	123	100	99	85	81	83
Total equity	724	761	582	595	510	616	774	1,205	1,414	1,651
Total liabilities and equity	2,373	2,304	2,007	2,271	2,271	2,234	2,450	2,727	2,966	3,386
Shares outstanding	28.2	26.5	24	24	24	24	24.1	27.7	27.2	26.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	91	192	174	81	-48	50	130	587	306	213
Depreciation and amortization	84	87	91	100	104	108	108	104	96	109
Stock-based compensation	8	12	8	17	18	18	26	34	41	45
Deferred income tax	-13	6	1	-5	7	0	-1	-403	-86	25
Change in receivables	-19	10	44	-33	51	-78	-156	13	61	6
Change in inventory	30	-3	1	13	-2	-92	-105	52	1	30
Change in payables	-10	-54	-19	73	-13	28	146	-130	-32	-4
Cash from operations	116	215	204	183	168	58	167	267	427	410
Capital expenditures	-75	-99	-127	-142
Acquisitions	-15	-47	16	0	0		0	0	-55	-50
Cash from investing	302	-173	-98	-128	-98	-63	-68	-123	-189	-181
Debt issued	0		0	0	400	0	350	0	0
Debt repaid	-2	-2	0	0	-400	0	-350	0	0
Stock issued	1	2	3	1		0	0	8	0	3
Share buybacks	-500	-200	-300	-20	-16	0	0	-107	-63	-57
Dividends paid								0	0	-15
Cash from financing	-2,262	-234	-335	-49	-58	-29	-9	-156	-100	-116
Exchange rate effect	-11	19	-13	-4	19	-11	-22	7	-30	34
Net change in cash	-1,855	-173	-242	2	31	-45	68	-5	108	147
Free cash flow	41	116	77	41
Interest paid	14	16	15	14	18	15	14	16	14	12
Income taxes paid	92	49	47	40	19	15	29	68	73	98

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $90.46 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.8%	Gross profit / revenue.
Pre-tax margin	7.2%	Pre-tax income / revenue.
Net margin	3.8%	Net income / revenue.
Operating cash flow margin	7.6%	Cash from operations / revenue.
Effective tax rate	43.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	8.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.1%	Net income / average total assets.
SG&A / revenue	5.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	3.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	0.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	16.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-32.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	17.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-31.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	12.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	34.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	19.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	17.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	32.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	32.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	14.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.78x	Current assets / current liabilities.
Quick ratio	1.29x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.64x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.18x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	8.2%	Total debt / total assets.
Liabilities / assets	51.1%	Total liabilities / total assets.
Net debt	-$364.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$787.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	2.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.51B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.09x	Revenue / average total assets.
Fixed asset turnover	7.21x	Revenue / average property, plant and equipment.
Inventory turnover	10.0x	Cost of revenue / average inventory.
Days inventory	36 days	365 x average inventory / cost of revenue.
Receivables turnover	5.67x	Revenue / average receivables.
Days sales outstanding	64 days	365 x average receivables / revenue.
Days payables	69 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	32 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.21	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$138.93	Revenue / diluted weighted shares.
Operating cash flow per share	$10.59	Cash from operations / diluted weighted shares.
Book value per share	$60.34	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$56.55	Tangible book value / shares outstanding.
Cash per share	$24.27	(Cash + short-term investments) / shares outstanding.
Payout ratio	24.5%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$2.41B	Share price x shares outstanding.
Enterprise value	$2.05B	Market cap + total debt - cash - short-term investments.
P/E	16.9x	Market cap / net income. Only when net income is positive.
P/S	0.64x	Market cap / revenue.
P/B	1.50x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.60x	Market cap / tangible book value, when positive.
P/OCF	8.38x	Market cap / cash from operations, when positive.
EV/Sales	0.54x	Enterprise value / revenue.
Earnings yield	5.9%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	5.0%	(Dividends paid + share buybacks) / market cap.
PEG	1.33x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was VISTEON CORP's revenue in fiscal 2025?

VISTEON CORP reported revenue of $3.77B for fiscal 2025, 2.5% lower than the year before.

Was VISTEON CORP profitable in fiscal 2025?

Yes. Net income was $201.0M, a net margin of 5.3%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to VISTEON CORP